By Freny Patel ( September 10, 2026, 01:28 GMT | Insight) -- India's draft pharmaceutical and biotechnology patent guidelines incorporate recent court rulings, giving life-sciences companies clearer guidance on patentability, evidentiary requirements, diagnostic inventions and the scope of permissible claims.India is giving pharmaceutical and biotechnology companies more detailed guidance on which inventions can secure patent protection, incorporating a series of court rulings into proposed examination standards for drugs, biologics and diagnostics....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.